Seoul, South Korea

Eun Kyung Ryu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eun Kyung Ryu: Innovator in Video Technology and Monoclonal Antibodies

Introduction

Eun Kyung Ryu is a notable inventor based in Seoul, South Korea. He has made significant contributions to the fields of video technology and biomedical research. With a total of 2 patents, Ryu's work showcases his innovative approach to solving complex problems.

Latest Patents

Ryu's latest patents include an "Encoding/decoding apparatus and method for parallel correction of in-loop pixels based on measured complexity, using video parameter." This invention involves a complexity measuring unit that assesses the complexity of an in-loop pixel correction process, utilizing video codec parameter information. Additionally, he has developed a "VCAM-1 specific monoclonal antibody," which specifically binds to vascular cell adhesion molecule-1 (VCAM-1 or CD106). This monoclonal antibody is significant as it is the first recombinant monoclonal antibody that is specific to both human and mouse VCAM-1, showing strong affinity and potential for treating VCAM-1 mediated diseases, particularly inflammatory diseases and cancer.

Career Highlights

Eun Kyung Ryu has worked with prominent companies such as Hanwha Chemical Corporation and Samsung Electronics Co., Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in his fields of work.

Collaborations

Ryu has collaborated with notable coworkers, including Junho Chung and Ji Eun Lee, who have contributed to his projects and research endeavors.

Conclusion

Eun Kyung Ryu's contributions to technology and medicine highlight his innovative spirit and dedication to advancing knowledge in his fields. His patents reflect a commitment to addressing complex challenges through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…